| Product Code: ETC7657787 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Opioid Induced Constipation Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 Israel Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 Israel Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.6 Israel Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 Israel Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of opioid-induced constipation in Israel |
4.2.2 Rising awareness about the importance of managing opioid-induced constipation |
4.2.3 Growing geriatric population in Israel requiring opioid therapy |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on opioid usage in Israel |
4.3.2 Limited availability of effective opioid-induced constipation drugs in the market |
5 Israel Opioid Induced Constipation Drugs Market Trends |
6 Israel Opioid Induced Constipation Drugs Market, By Types |
6.1 Israel Opioid Induced Constipation Drugs Market, By Active Ingredients |
6.1.1 Overview and Analysis |
6.1.2 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Active Ingredients, 2021- 2031F |
6.1.3 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Naloxegol, 2021- 2031F |
6.1.4 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.5 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Methylnaltrexone Bromide, 2021- 2031F |
6.1.6 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Docusate Sodium, 2021- 2031F |
6.1.7 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Opioid Induced Constipation Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Over The Counter Medicines, 2021- 2031F |
6.2.3 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Prescription, 2021- 2031F |
6.2.4 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Natural Remedies, 2021- 2031F |
6.3 Israel Opioid Induced Constipation Drugs Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Opioid Induced Constipation Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Opioid Induced Constipation Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Israel Opioid Induced Constipation Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Opioid Induced Constipation Drugs Market Import-Export Trade Statistics |
7.1 Israel Opioid Induced Constipation Drugs Market Export to Major Countries |
7.2 Israel Opioid Induced Constipation Drugs Market Imports from Major Countries |
8 Israel Opioid Induced Constipation Drugs Market Key Performance Indicators |
8.1 Number of healthcare providers trained on opioid-induced constipation management |
8.2 Patient adherence to prescribed opioid-induced constipation medications |
8.3 Number of clinical trials for new opioid-induced constipation drugs in Israel |
9 Israel Opioid Induced Constipation Drugs Market - Opportunity Assessment |
9.1 Israel Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
9.2 Israel Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 Israel Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Opioid Induced Constipation Drugs Market - Competitive Landscape |
10.1 Israel Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here